A classification based on tumor budding and immune score for patients with hepatocellular carcinoma
Background: The role of immune profiling and tumor budding in hepatocellular carcinoma (HCC) remains largely unknown. This study evaluated the association between tumor budding and lymphocytic infiltration in HCC. Meanwhile, HCC patients were stratified based on tumor budding grade and immune score....
Main Authors: | Li Wei, Zhang Delin, Yuan Kefei, Wu Hong, Huang Jiwei, Zhang Yange |
---|---|
Format: | Article |
Language: | English |
Published: |
Taylor & Francis Group
2020-01-01
|
Series: | OncoImmunology |
Subjects: | |
Online Access: | http://dx.doi.org/10.1080/2162402X.2019.1672495 |
Similar Items
-
Prognosis and personalized medicine prediction by integrated whole exome and transcriptome sequencing of hepatocellular carcinoma
by: Debao Li, et al.
Published: (2023-02-01) -
Tumor budding in laryngeal carcinoma
by: Sumeyye Ekmekci, et al.
Published: (2019-01-01) -
Cross Analysis of Genomic-Pathologic Features on Multiple Primary Hepatocellular Carcinoma
by: Fei Ren, et al.
Published: (2022-06-01) -
Hepatocellular carcinoma immune prognosis score predicts the clinical outcomes of hepatocellular carcinoma patients receiving immune checkpoint inhibitors
by: Rujia Zhang, et al.
Published: (2023-12-01) -
Sporadic PCDH18 somatic mutations in EpCAM-positive hepatocellular carcinoma
by: Takehiro Hayashi, et al.
Published: (2017-10-01)